Sunday, January 27, 2013

Where the Actos Lawsuits Stand

Actos is a prescription drug manufactured by Takeda, a Japanese pharmaceutical corporation, over thirteen years ago and is used in the treatment of Type 2 diabetes. While there were many adverse health issues reported among users of Actos, the drug remains on the market even though France and Germany have withdrawn it from their markets. Actos has been definitively linked to a much higher rate of bladder cancer among users and can also increase the risk of adverse cardiovascular events, liver problems and macular edema. For patients who have taken the drug for periods longer than a year or in especially high dosages, there may be as much as a forty percent increase in the incidence of bladder cancer. Although bladder cancer is treatable, it has an extremely high rate of recurrence therefore Actos users may find their lives forever changed from a drug they believed to be safe.

The FDA issued a warning to Actos users in 2010 regarding its potential cancer risks, however were slow to take any further action until June of 2011 when they ordered Takeda to add new warnings to the labeling of Actos. The first Actos lawsuit was filed in July of 2011, with numerous more that followed. Bloomberg reported in March of 2012 that Takeda could easily face as many as 10,000 claims related to Actos bladder cancer. The majority of the lawsuits are expected to allege that the Takeda and Eli Lilly were aware of the increased risk of bladder cancer among Actos users but failed to adequately warn patients.

On June 12, 2012, a New York woman filed a $10 million dollar lawsuit against Takeda, alleging she developed bladder cancer as a direct result of taking Actos for five years. In September of 2012, the Canadian Medical Association Journal stated that those taking the drug Actos for the treatment of Type 2 diabetes were at a significantly increased risk of developing bladder cancer. Despite the controversy surrounding the drug, the FDA approved the first generic version of Actos on August 17, 2012—albeit with a warning label which notes the increased risk of bladder cancer among those taking the drug for longer than a year.

According to the most recent court documents, a lawsuit was filed in the Superior Court of Los Angeles by an Actos user who is alleging bladder cancer as the result of taking the drug. This lawsuit is set for trial on February 19^th, 2013. This is expected to be a very important case for the future of those injured by Actos and is just one of many Actos bladder cancer lawsuits pending in a consolidated proceeding underway in Los Angeles Superior Court. Aside from the California proceedings there are hundreds of Actos lawsuits pending in an MDL in the Western District of Louisiana, with the first trial set for November of 2014, and the second in July, 2015.

Actos users who developed bladder cancer after taking the drug could be entitled to compensation for the medical expenses they have been subject to, lost wages and pain and suffering.

Author: Sullo & Sullo Attorneys

0 Comments

Categories: ImportedNumber of views: 1769

Tags: actos Attorneys actos class action lawsuit actos congestive heart failure lawsuit actos heart failure lawsuits actos lawsuit actos lawsuits

Please login or register to post comments.

250,000 CLIENTS REPRESENTED

FREE CASE REVIEW

Full Name* Email* Telephone Number* Are You already a Client?* Type of Case* Tell Us About Your Case*

WARNING: Do not send any information in any email through this website if you consider the information confidential or privileged.

I understand that by submitting my contact information to Sullo & Sullo LLP for review, I consent to messages regarding this legal matter as well as marketing for other potential legal matters in the future without limitation at standard messaging and data rates unless terminated by me in writing. I further understand that my submission of any and all information in response to this website does NOT create a lawyer-client relationship between myself and Sullo & Sullo, LLP and/or its lawyers, and that any and all information submitted is NOT confidential or privileged. I further acknowledge that, unless Sullo & Sullo, LLP subsequently enters into an Attorney-Client relationship with me, any and all information I provide will NOT be treated as confidential or privileged, and any such information may be used against me and/or for the benefit of current or future clients of Sullo & Sullo, LLP. ...READ ENTIRE DISCLAIMER

Receive an Immediate Response

ANDREW SULLO IS A TOP 100 NATIONAL TRIAL LAWYER 2013 • 2014 • 2015 • 2016 • 2017 • 2018 • 2019

Obtener una Respuesta Inmediata

Andrew Sullo – 100 Mejores Abogados Nacional | 2013 • 2014 • 2015 • 2016 • 2017